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Mitral stenosisAbstract Introduction: Conventional echocardiographic parameters are not able to detect sub-
clinical left ventricular (LV) systolic dysfunction in patients with mitral stenosis (MS). Two-dimen-
sional (2D) longitudinal strain (S) and strain rate (Sr) imaging is a new technique which evaluates
global LV systolic function with high reproducibility. The aim of the study was to assess LV systolic
function, in patients with moderate–severe MS and normal ejection fraction (EF%), by 2D longi-
tudinal systolic S and Sr imaging.
Patients and method: The study included 50 patients with an established diagnosis of MS (mean
age: 32 ± 8 years) and 30 age-matched healthy individuals (mean age 34 ± 7 years). The mitral
valve area (MVA) was measured by planimetry and pressure half time (PHT) methods. 2D longi-
tudinal systolic S and Sr imaging was performed for each participant from the apical long axis
(LAX), 4 chamber (4C) and 2 chamber (2C) views. Global longitudinal systolic S and Sr were cal-
culated by averaging the three apical views.
Results: There were no signiﬁcant differences in LV EF%, LV end-systolic and end-diastolic
dimensions between the two groups. Patients with MS had signiﬁcantly lower 2D longitudinal
LV systolic S and Sr compared to the control group (<0.001 and <0.05 respectively).
Conclusion: Patients with MS and preserved EF% had lower 2D longitudinal LV systolic S and Sr
compared to the control group. 2D longitudinal LV systolic S and Sr imaging appears to be useful
in the detection of subclinical LV systolic dysfunction in patients with MS and preserved EF%.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
The most common pathophysiologic cause of mitral stenosis
(MS) is rheumatic disease.1 Generally; LV systolic function
in isolated MS is well preserved.2 In some patients with MS,
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impair the LV contractile function.3 The presence of impaired
LV systolic function, determined by M-mode and/or two-
dimensional echocardiography was noted only in 25–30% of
patients with MS.4
Conventional echocardiographic parameters are not able to
demonstrate subclinical LV dysfunction in patients with MS.1
Recently, two-dimensional (2D) strain and strain rate imaging
is used for the quantitative assessment of global and segmental
LV function from 2D images.2
Strain (S) deﬁnes the myocardial deformation, and strain
rate (Sr) deﬁnes the rate of deformation. S and Sr can be
obtained either as tissue Doppler imaging (TDI) or 2D speckle
tracking–derived parameters. 2D speckle tracking imaging of
the S and Sr overcomes the major limitations of the TDI (teth-
ering and the rotation motion of the heart).5
1.1. Aim of the study
To assess LV systolic function, in patients with moderate–
severe MS and normal EF%, by 2D longitudinal systolic S
and Sr imaging
2. Patients and methods
The study subjects consisted of 50 patients with established
diagnosis of MS (40 women and 10 men, mean age:
32 ± 8 years) and 30 age-matched healthy individuals (24
women and 6 men, mean age: 34 ± 7 years). The study was
approved by the ethics committee of the hospital and all
included subjects have consented to be enrolled in this study.
2.1. Exclusion criteria
Patients with coronary artery disease (CAD) and apparent LV
wall motion abnormalities.
1. Patients with LV systolic dysfunction (EF%< 50%).
2. Patients with cardiac rhythm or conduction disturbances
such as atrial ﬁbrillation or artiﬁcial pacing.
3. Patients with concomitant moderate or severe mitral
regurgitation, aortic stenosis and aortic regurgitation.
Each person included in the study was subjected to:
1. Careful history taking and thorough physical
examination
2. Standard twelve-lead electrocardiogram: For assessment
of cardiac rhythm and features suggesting chamber
enlargement and CAD.
3. Basic echocardiographicmeasurements:Echocardiography
was performed using an Aplio 400, Toshiba, Japan ultr-
asonographic machine with an M4S transducer. Patients
were monitored through a single-lead electrocardiogram.
The left atrial diameter, left ventricular end-systolic and
end-diastolic diameters, left ventricular fractional
shortening percentage, the thickness of the interventricu-
lar septum (IVS), and the posterior wall (PW) were
measured according to the recommendations of the
American Society of Echocardiography.6 The LV ejection
fraction was calculated by Simpson’s biplane method ofdisks. Conventional MS indices, such as maximummitral
valve pressure gradient (PG) and mean mitral valve
pressure gradient (MG)were calculated.Mitral valve area
(MVA) was measured by mitral oriﬁce planimetry in
parasternal short axis view, and by the Doppler derived
pressure halftime method (PHT) and the average area
was calculated by the mean value of two measurements.
MS severity was calculated based on hemodynamic data,
using MVA, MG and pulmonary artery systolic pressure
(PAP) as follows: mild MS (MVA> 1.5 cm2, MG<
5 mmHg, or PAP < 30 mmHg), moderate MS (MVA
1.0–1.5 cm2, MG 5–10 mmHg, or PAP 30–50 mmHg),
and severe MS (MVA< 1.0 cm2, MG> 10 mmHg, or
PAP > 50 mmHg). PAP was measured by adding
10 mmHg, considering the diameter of the inferior vena
cava and level of its collapse resulting from respiration,
to the value measured by evaluating the Bernoulli
equation, which is simpliﬁed from tricuspid insufﬁciency
velocities. The valvular insufﬁciency was evaluated by
color ﬂow Doppler imaging.
4. Measurement of the 2D strain and strain rate: 2D echo-
cardiography images (transmit/receive 1.9/4.0 MHz)
were obtained from LV apical LAX,4C, and 2C views
with frame rates of 50–90 frames/s. Digital data were
stored and analyzed off-line. LV endocardial surface
was traced manually, and the speckle tracking width
was modiﬁed so as to cover the whole LV wall thickness
to obtain curves. Peak LV longitudinal systolic strain
(LSS) and strain rate (LSSr) were calculated for apical
LAX, 4C, and 2C views, and global LV systolic strain
(GLSS) and strain rate (GLSSr) were calculated by aver-
aging the three apical views as shown in Figs. 1–3. All
the echocardiographic studies were performed by one
echocardiographer and for intra-observer variability, a
sample of 2D strain and strain rate measurements was
randomly selected and examined by the same observer
in two different days and intra-class correlation coefﬁ-
cients for the same observer were calculated.
3. Statistical analysis
Collected data were computerized and analyzed using Statisti-
cal Package for Social Science (SPSS) version 16. Quantitative
variables were expressed as mean ± standard deviation (SD).
Student‘s t-test was used to compare the normally distributed
continuous variable between patients with MS and the healthy
control group.
4. Results
4.1. Demographic and conventional echocardiographic
characteristic
Age and gender indices were similar in the control group and
patients with MS (p> 0.05), heart rate was signiﬁcantly higher
in patients with MS compared to the control group (p< 0.05).
There was no signiﬁcant difference between systolic and dia-
stolic blood pressures in patients with MS compared to the
control group (p> 0.05). There was no signiﬁcant difference
in IVS and PW thickness, LVESD, LVEDD, LVESV,
Figure 1 Two-dimensional strain and strain rate imaging of the apical long axis (A), 4 chamber (B) and 2 chamber (C) views in a healthy
subject.
Figure 2 Apical 4 chamber longitudinal strain curves in a healthy subject.
Figure 3 Apical 4 chamber longitudinal strain rate curves in a healthy subject.
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control group (p> 0.05), LA diameter was signiﬁcantly
increased in patients with MS compared to the control group(<0.001). Transmitral PG was 21.2 ± 3.1 mmHg, transmitral
MG was 11.5 ± 2.0 mmHg and mean MVA was
0.95 ± 0.15 cm2 in patients with MS as shown in Table 1.
Table 1 Clinical and echocardiographic features of the study groups.
Control MS P value
Age, years 34 ± 7 32 ± 8 NS
Female/male 24 / 6 40 / 10 NS
Heart Rate (bpm) 65 ± 6 78 ± 12 <0.05
SBP (mmHg) 118 ± 9 111 ± 7 NS
DBP (mmHg) 80 ± 6 77 ± 5 NS
IVS thickness (cm) 0.85 ± 0.12 0.83 ± 0.11 NS
PWT (cm) 0.87 ± 0.09 0.87 ± 0.08 NS
LV end-diastolic diameter (cm) 4.87 ± 0.34 4.58 ± 0.52 NS
LV end-systolic diameter (cm) 3.26 ± 0.33 3.12 ± 0.45 NS
LV end-diastolic volume (ml) 105 ± 21 101 ± 18 NS
LV end-systolic volume (ml) 35 ± 10 38 ± 12 NS
EF (%) 66 ± 4 62 ± 3 NS
FS (%) 33 ± 5 31 ± 5 NS
LA diameter (cm) 3.45 ± 0.3 4.82 ± 0.25 <0.001
MVA (cm2) – 0.95 ± 0.15 –
PG (mmHg) – 21.2 ± 3.1 –
MG (mmHg) – 11.5 ± 2.0 –
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; IVS, interventricular septum; PWT, posterior wall thickness; LV, left
ventricle; EF; ejection fraction, FS, fractional shortening; MVA, mitral valve area; PG, transmitral peak gradient; MG, mean gradient.
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There was a highly signiﬁcant lower peak LV longitudinal
systolic strain (LAX-LSS, 4C-LSS, 2C-LSS and GLSS) in
patients with MS compared to the control group (<0.001).
There was a signiﬁcantly lower peak LV longitudinal systolic
strain rate (LAX-LSSr, 4C-LSSr, 2C-LSSr and GLSSr) in
patients with MS compared to the control group (<0.05), as
shown in Table 2.
Pearson correlation coefﬁcient revealed a signiﬁcant posi-
tive correlation between GLSS with EF% (r= 0.33,
p= 0.01) and MVA (r= 0.40, p= 0.001), and a signiﬁcant
negative correlation between GLSS with PG (r= 0.36,
p= 0.007) and MG (r= 0.40, p= 0.003) in patients with
MS. There was a signiﬁcant positive correlation between
GLSSr with EF% (r= 0.39, p= 0.02) and MVA (r= 0.52,Table 2 Systolic strain and strain rate measurements of the
study groups.
Control MS P value
LAX-LSS (%) 18.8 ± 2.43 12.62 ± 1.7 <0.001
4C-LSS (%) 18.9 ± 3.22 13.18 ± 1.1 <0.001
2C-LSS (%) 18.3 ± 2.81 12.51 ± 1.5 <0.001
GLSS (%) 18.6 ± 2.82 12.77 ± 1.4 <0.001
LAX-LSSr (s1) 1.25 ± 0.31 1.02 ± 0.42 <0.05
4C-LSSr (s1) 1.28 ± 0.38 1.05 ± 0.18 <0.05
2C-LSSr (s1) 1.22 ± 0.33 1.01 ± 0.31 <0.05
GLSSr (s1) 1.25 ± 0.34 1.02 ± 0.30 <0.05
Abbreviations: LAX-LSS, apical long axis longitudinal systolic
strain; 4C-LSS, apical 4 chamber longitudinal systolic strain; 2C-
LSS, apical 2 chamber longitudinal systolic strain; GLSS, left
ventricular global longitudinal systolic strain; LAX-LSSr, apical
long axis longitudinal systolic strain rate; 4C-LSSr, apical 4
chamber longitudinal systolic strain rate; 2C-LSSr,2 chamber
longitudinal systolic strain rate; GLSSr, left ventricular global
longitudinal systolic strain rate.p= 0.001), and a signiﬁcant negative correlation between
GLSSr with PG (r= 0.43, p= 0.005) and MG
(r= 0.42, p= 0.006) in patients with MS, as shown in
Table 3.
Intra-class correlations for intra-observer variability were
also good for global LV longitudinal systolic strain (0.90,
95% CI 0.75–0.95); and global LV longitudinal systolic strain
rate (0.92, 95% CI 0.78–0.97).
5. Discussion
LV function in patients with mitral stenosis has been exten-
sively investigated during the last decades.7 Earlier angio-
graphic studies found lower EF% in patients with MS than
in controls,8,9 ventriculography studies showed distorted con-
traction of the postero-basal segment due to scarring of the
mitral valve complex and ﬁbrosis of the papillary muscle10
and some angiographic studies found generalized rather than
regional LV dysfunction.11 Echocardiography allowed better
visualization of the mitral valve, cardiac structure and func-Table 3 Correlations between GLSS and GLSSr values and
echocardiographic parameters.
GLSS GLSSr
r value P value r value P value
PG 0.36 0.007 0.43 0.005
MG 0.40 0.003 0.42 0.006
MVA 0.40 0.001 0.52 0.001
PAP 0.03 0.54 0.01 0.39
LA diameter 0.12 0.44 0.14 0.47
EF% 0.33 0.01 0.39 0.02
Abbreviations: PG, transmitral peak gradient; MG, mean gradient;
MVA, mitral valve area; PAP, pulmonary artery pressure; LA, left
atrium; GLSS, global longitudinal systolic strain; GLSSr, global
longitudinal systolic strain rate.
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independent LV contractile dysfunction; however, strain and
strain rate imaging might show impaired long axis systolic
velocity despite normal global systolic function.12
Strain is a measure of ﬁber shortening, and strain rate mea-
sures the rate of deformation. So, both of these methods pro-
vide complementary data about the global and regional
myocardial function.13 TDI-derived strain imaging is highly
angle dependent and only measures deformation in one dimen-
sion. On the other hand 2D strain analysis does not have angle
limitations, allows deformation analysis in two dimension,
lower intra-observer and inter-observer variability, and less
time-consuming technique. Thus, 2D strain imaging may
reﬂect subclinical heart disease, and true wall motion that can-
not be identiﬁed by the TDI-derived strain analysis.14
Our study evaluated peak longitudinal left ventricular sys-
tolic strain and strain rate in patients with rheumatic MS
and normal left ventricular systolic function. Peak longitudinal
LV systolic strain (LAX-LSS, 4C-LSS, 2C-LSS and GLSS)
was highly signiﬁcantly decreased in patients with rheumatic
MS compared to the control group (<0.001). Peak longitudi-
nal LV systolic strain rate (LAX-LSSr, 4C-LSSr, 2C-LSSr and
GLSSr) was signiﬁcantly decreased in patients with MS com-
pared to the control group (<0.05).
Our result can be explained by long term sequelae of rheu-
matic fever, the endocardium and myocardium could be
affected to varying degrees which results in the loss of nor-
mally functioning myocytes, myocytes necrosis and replace-
ment by ﬁbrosis and calciﬁcation.1 LV ﬁbers at the
subendocardial site array longitudinally and converge with
the mitral annulus, in addition the anterior mitral valve leaﬂet
bound to the septum and the ﬁbrous annulus of the heart, con-
sequently pathological events that affect the mitral valve can
involve the LV as well.15 By the use of electron beam micros-
copy Lee and Lee3 revealed varying degrees of ultra structural
pathological alterations of LV muscle cells, including the myo-
ﬁbrils, mitochondria, nuclei and other elements of the sarco-
plasm. Furthermore, the combination of rigid mitral valve,
abnormal IVS motion due to right ventricular volume over-
load, altered right and left ventricular interaction and reﬂex
increase in the after load may contribute to LV systolic dys-
function in patients with MS.7 As the global and regional func-
tion of the LV myocardium is related to the number of
normally functioning myocytes, conventional echocardio-
graphic parameters may not determine subclinical LV systolic
dysfunction. On the other hand, the recent technical develop-
ments of 2D strain and strain rate imaging are able to detect
subclinical myocardial dysfunction.16,17
Our result was in agreement with that of Yildirimtu¨rk et al.2
who found signiﬁcantly decreased longitudinal and circumfer-
ential S and Sr in patients with MS compared with healthy
subjects (p< 0.001). In addition Ozdemir et al.1 reported sig-
niﬁcantly reduced GLSS and GLSSr in patients with isolated
MS compared with healthy subjects (GLSS 17 ± 3.3 vs.
19 ± 2.5%, P= 0.006 and GLSSr 1.3 ± 0.3 vs.
1.5 ± 0.3 s1, P< 0.0001) despite normal LV systolic func-
tion as assessed by EF% (66 ± 8%).
Dogan et al.12 found a lower peak systolic strain rate
(1.2 ± 0.4% vs. 1.8 ± 0.39%, P< .001) and end-systolic
strain values (10 ± 5 vs. 25 ± 6 s1, P< .001) at the IVS
and basal segment of the lateral LV wall in patients with pure
MS, who had normal EF% compared to healthy subjects. Liet al.18 found signiﬁcantly reduced GLSS in patients with iso-
lated mild to moderate rheumatic MS with normal LV systolic
function as assessed by EF% (P< 0.05). Regional analysis
demonstrated that patients with MS had a signiﬁcantly
reduced regional peak strain in all basal, and some mid (infe-
rior, anteroseptal, posteroseptal) segments of the LV.
In mitral stenosis, if it is considered that ﬁbrosis primarily
affects the valve and adjacent structures, measurements only
at a basal level might not be appropriate and any comment
about global LV functions based on these measurements will
be wrong. Therefore, we measured not only the strain and
strain rate at a basal level, but also at the 6 LV walls of the api-
cal LAX, 4C and 2C views.
In our study, Pearson correlation analysis revealed a signif-
icant positive correlation between left ventricular GLSS with
EF% (r= 0.33, p= 0.01) and MVA (r= 0.40, p= 0.001)
and a signiﬁcant negative correlation between left ventricular
GLSS with PG (r= 0.36, p= 0.007) and MG (r= 0.40,
p= 0.003) in patients with MS. In addition, there was a signif-
icant positive correlation between left ventricular GLSSr with
EF% (r= 0.39, p= 0.02) and MVA (r= 0.52, p= 0.001)
and a signiﬁcant negative correlation between left ventricular
GLSSr with PG (r= 0.43, p= 0.005) and MG
(r= 0.42, p= 0.006) in patients with MS.
Our result was in agreement with that of Li et al.18 who
found that patients with MS had lower LV-GLSS and corre-
sponded with LV EF% (r= 0.601, P< 0.001). In addition
Bilen et al.19 found a signiﬁcantly lower LV strain and strain
rate in patients with MS compared with healthy subjects.6. Conclusion
Patients with MS and preserved EF% had a lower 2D longitu-
dinal LV systolic S and Sr compared to the control group. 2D
longitudinal LV systolic S and Sr imaging appears to be useful
in the detection of subclinical LV systolic dysfunction in
patients with MS and preserved EF%.
7. Study limitations
Potential limitation of the present study is the relatively small
sample size so the results may not be generalized. As only stan-
dard apical images were obtained, we could only measure lon-
gitudinal strain and strain rate parameters, so neither
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